ArticleAnnals of translational medicine2020

The potential adjunctive benefit of adding metformin to standard treatment in inoperable cancer patients: a meta-analysis of randomized controlled trials.

Zhonghua Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.